Gestodene, a new synthetic progestogen, binds to progesterone receptor (PR) derived from
normal breast, endometrium and both normal and diseased liver with an affinity 8-10 times …

The effects of a 24-day regimen containing 15 μg ethinyl estradiol (EE) plus 60 μg
gestodene on cycle control and on hemostasis, were evaluated in 58 healthy women (age …

Gestodene (17 alpha-ethynyl-13 beta-ethyl-17 beta-hydroxy-4, 15-gonadien-3-one) is the
most potent synthetic progestin currently available and it is widely used as a fertility …

During one year of treatment with oral contraceptives containing 30 μg ethinylestradiol and
150 μg desogestrel (EE DG) or 30 μg EE and 75 μg gestodene (EE GSD), the serum …

Objective: To compare ovulation inhibition and ovarian activity with 21-day and 24-day
regimens of a low-dose combined oral contraceptive (COC) containing 60 μg of gestodene …

Objectives: The safety and contraceptive efficacy of a new 24-day regimen of an oral
contraceptive combination containing gestodene (GTD) 60 µg and ethinylestradiol (EE) 15 …

The serum protein binding of levonorgestrel, gestodene and 3-keto-desogestrel has been
determined during several clinical studies with different oral contraceptive formulations and …

Fifteen healthy women participated in a study to determine the effect of multiple doses of
troglitazone on the pharmacokinetics of Ortho‐Novum 1/35 (35 μg ethinyl estradiol [EE] and …

In this double-blind study we compared the influence of two oral contraceptives, a 23-day
regimen with 20 μg ethinyl estradiol and 75 μg gestodene (23-day 20/75) and a 21-day …

Combined progestin–estrogen pills are an established and reliable contraceptive option
used by women worldwide. Combined oral contraceptives (COCs) containing the progestins …